COMMUNIQUÉS West-GlobeNewswire

Nash Pharmaceuticals Announces Positive Pre-Clinical Results For Its Lead Compound NP-135 in Chronic Kidney Disease
19/11/2018
Planning Phase II Trial VANCOUVER, B.C., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: BTH ) (FRANKFURT: BTI) (OTCQB: BTHCD) (the [...]
Axsome Therapeutics to Participate in 2018 Global Mizuho Investor Conference
19/11/2018
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Canopy Rivers Portfolio Company Radicle Receives Licence From Health Canada to Commence Sales of Premium Craft Cultivated Product
19/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (“ Canopy Rivers ” or the “ Company ”) (TSXV:RIV) congratulates its portfolio company, [...]
Emerald Health Therapeutics Receives TSX Venture Conditional Approval of Emerald Health Naturals Joint Venture
19/11/2018
Joint venture to d istribute endocannabinoid-supporting products to Canadian natural health product stores and pharmacies VICTORIA, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc [...]
Microbix Wins Business Award of Excellence
19/11/2018
Recognized with 2018 Business Innovation Award by MBOT TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it [...]
Evogene Announces Establishment of Ag-Chemicals Subsidiary – AgPlenus Ltd.
19/11/2018
Evogene’s activities relating to design and development of effective and safe next generation agro-chemical products transferred to new subsidiary REHOVOT, Israel, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ [...]
Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018
19/11/2018
WALTHAM, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
ContraFect to Present at Piper Jaffray Health Care Conference
19/11/2018
YONKERS, N.Y., Nov. 19, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Avivagen’s Asian partner UNAHCO continues to ramp-up use of OxC-beta™ Livestock with new large order
19/11/2018
OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tonnes of OxC-beta™ Livestock. This follows a 2 [...]
BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium
19/11/2018
Positive proof of concept data with Bria-IMT™ Monotherapy will highlight potent anti-tumor activity and an excellent safety profile for Bria-IMT™ in advanced breast cancer. Patient dosing is ongoing in a combination [...]
Evolus Receives Conditional FDA Acceptance of Jeuveau™ Brand Name
19/11/2018
Less Than 90 days to FDA Action Date for Jeuveau IRVINE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the conditional acceptance from [...]
Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health
19/11/2018
Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter [...]
Transactions under Novozymes’ stock buyback program
19/11/2018
Please read the full announcement in the attached PDF Attachment 2018_64_Stock_Buybackprogram_EN
Active Biotech's election committee appointed
19/11/2018
PRESS RELEASE In accordance with a decision made by the Annual General Meeting held on May 17, 2018, the Election Committee shall comprise the representatives for the three largest shareholders by votes, as per end of [...]
Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech
19/11/2018
PRESS RELEASE Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech First-in-human clinical trial of IMC-C103C scheduled to commence in 2019 in multiple solid tumour indications ( [...]
GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES
19/11/2018
FOR IMMEDIATE RELEASE GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES Lille (France), Cambridge (Massachusetts, United States), November 19, 2018 - GENFIT SA (Euronext: GNFT), a French [...]
GENFIT ANNONCE SON INTENTION DE PROCÉDER À UNE OFFRE AU PUBLIC AUX ÉTATS-UNIS
19/11/2018
POUR DIFFUSION IMMÉDIATE GENFIT ANNONCE SON INTENTION DE PROCÉDER À UNE OFFRE AU PUBLIC AUX ÉTATS-UNIS Lille (France), Cambridge (Massachusetts, États-Unis), le 19 novembre 2018 - GENFIT SA (Euronext : GNFT), une [...]
Sonoma Pharmaceuticals Announces Pricing of Public Offering of Units
17/11/2018
PETALUMA, Calif., Nov. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of a “best efforts” public offering of units consisting of one share of common stock, together [...]
Teligent, Inc. Receives Notification of Deficiency From NASDAQ Related to the Delayed Filing of Form 10-Q
16/11/2018
BUENA, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having timely filed its quarterly report on Form [...]

Pages